Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Schizophrenia

  Free Subscription


Articles published in Pharmacopsychiatry

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    January 2019
  1. TASMIM S, Kolla NJ, Dada O, Bani-Fatemi A, et al
    Correlation Between Violence and Antipsychotic Dosage in Schizophrenia: A Secondary Analysis of The Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) Dataset.
    Pharmacopsychiatry. 2019 Jan 22. doi: 10.1055/a-0826-4935.
    PubMed     Text format     Abstract available


  2. ZHENG W, Zhang QE, Cai DB, Yang XH, et al
    Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2019;52:24-31.
    PubMed     Text format     Abstract available


    September 2018
  3. SCHENNACH R, Riedel M, Spellmann I, Musil R, et al
    Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
    Pharmacopsychiatry. 2018 Sep 20. doi: 10.1055/a-0669-9461.
    PubMed     Text format     Abstract available


    July 2018
  4. OLIVEIRA P, Coroa M, Madeira N
    Treatment Options for Insomnia in Schizophrenia: A Systematic Review.
    Pharmacopsychiatry. 2018 Jul 30. doi: 10.1055/a-0658-1645.
    PubMed     Text format     Abstract available


  5. KROC A, Debicka M, Wierzbicka A, Wolkow L, et al
    Sertindole: EEG Analysis, Tolerability, and Clinical Efficacy.
    Pharmacopsychiatry. 2018;51:144-147.
    PubMed     Text format     Abstract available


    May 2018
  6. YOSHIDA K, Uchida H, Suzuki T, Watanabe M, et al
    Prediction Model of Serum Lithium Concentrations.
    Pharmacopsychiatry. 2018;51:82-88.
    PubMed     Text format     Abstract available


    March 2018
  7. KISHI T, Matsui Y, Matsuda Y, Katsuki A, et al
    Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pharmacopsychiatry. 2018 Mar 7. doi: 10.1055/a-0574-0088.
    PubMed     Text format     Abstract available


  8. ROSER P, Pichler EM, Habermeyer B, Kawohl W, et al
    Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
    Pharmacopsychiatry. 2018 Mar 5. doi: 10.1055/a-0573-9866.
    PubMed     Text format     Abstract available


    January 2018
  9. DEMBLER-STAMM T, Fiebig J, Heinz A, Gallinat J, et al
    Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls.
    Pharmacopsychiatry. 2018 Jan 29. doi: 10.1055/s-0044-100627.
    PubMed     Text format     Abstract available


    July 2017
  10. LI XB, Zheng W, Ning YP, Cai DB, et al
    Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.
    Pharmacopsychiatry. 2017 Jul 17. doi: 10.1055/s-0043-114670.
    PubMed     Text format     Abstract available


  11. NAGAI N, Tani H, Suzuki T, Ikai S, et al
    Patients' Knowledge about Prescribed Antipsychotics and Medication Adherence in Schizophrenia: A Cross-Sectional Survey.
    Pharmacopsychiatry. 2017 Jul 4. doi: 10.1055/s-0043-113828.
    PubMed     Text format     Abstract available


  12. MAURI MC, Paletta S, Di Pace C, Reggiori A, et al
    Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.
    Pharmacopsychiatry. 2017;50:145-151.
    PubMed     Text format     Abstract available


    May 2017
  13. SCHENNACH R, Obermeier M, Seemuller F, Jager M, et al
    Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?
    Pharmacopsychiatry. 2017 May 15. doi: 10.1055/s-0043-106436.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: